AFMD - Affimed N.V. (AFMD) Q1 2024 Earnings Call Transcript
2024-06-12 10:48:05 ET
Affimed N.V. (AFMD)
Q1 2024 Earnings Conference Call
June 12, 2024 08:30 A.M. ET
Company Participants
Alexander Fudukidis – Head, IR
Andreas Harstrick – CMO and Interim CEO
Michael Wolf – VP, Finance
Conference Call Participants
Srikripa Devarakonda - Truist Securities
Daina Graybosch - Leerink Partners
Maury Raycroft - Jefferies
Li Watsek - Cantor Fitzgerald
Yale Jen - Laidlaw & Company
Bradley Canino - Stifel, Nicolaus & Company
Presentation
Operator
Good day, everyone and welcome to Affimed's First Quarter 2024 Earnings and Corporate Update Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will be given at that time. As a reminder, today's conference call is being recorded. I would now like to introduce your host for today’s call, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.
Alexander Fudukidis
Thank you, Michelle, and thank you all for joining us today for our first quarter 2024 update call. Before we begin, I'd like to remind everyone that we issued the relevant press release and presentation on our website today, which you can find under the -- in the Investor Relations section. On the call today, we have members of our management team, including Andreas Harstrick, our Chief Medical Officer and Acting Chief Executive Officer; Wolfgang Fischer, our Chief Operating Officer; Denise Mueller, our Chief Business Officer; and Harry Welten, our Consulting Chief Financial Officer. Our financials today will be presented by our Vice President of Finance, Michael Wolf. The team will be available for Q&A after the prepared remarks.
Before we start, I would like to remind you that today's presentation contains projections and forward-looking statements regarding future events. These statements represent our beliefs and assumptions only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in the future and the forward-looking statements, even if new information becomes available in the future. These forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in these statements due to various factors, including, but not limited to, those identified under the section entitled Risk Factors in our filings with the SEC, and those identified under the section entitled Forward-Looking Statements in the press release that we issued today and filed with the SEC....
Affimed N.V. (AFMD) Q1 2024 Earnings Call Transcript